The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages.

This study indicates that the effect of Etanercept may be influenced by residing macrophages in tumor microenvironment, and suggests a method to predict the effect of drugs in the presence of stromal cells to guide experimental designs in drug development.